Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Pancreatic Neoplasms Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Hypoxia-Inducible Factor 1 Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Apoptosis Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
bcl-2-Associated X Protein Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Jihui Hao
20032019

Research Output 2003 2019

HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarcinoma

Wang, H., Jia, R., Zhao, T., Li, X., Lang, M., Lan, C., Wang, H., Li, Z., Zhou, B., Wu, L., Sun, Y., Wang, X., Ren, H. & Hao, J., Jul 1 2019, In : Cancer Letters. 453, p. 10-20 11 p.

Research output: Contribution to journalArticle

Granulocyte-Macrophage Colony-Stimulating Factor
Adenocarcinoma
Up-Regulation
Neoplasms
Schwann Cells

Targeted co-delivery of the iron chelator deferoxamine and a HIF1α inhibitor impairs pancreatic tumor growth

Lang, J., Zhao, X., Wang, X., Zhao, Y., Li, Y., Zhao, R., Cheng, K., Li, Y., Han, X., Zheng, X., Qin, H., Geranpayehvaghei, M., Shi, J., Anderson, G. J., Hao, J., Ren, H. & Nie, G., Feb 26 2019, In : ACS Nano. 13, 2, p. 2176-2189 14 p.

Research output: Contribution to journalArticle

Hypoxia-Inducible Factor 1
Deferoxamine
hypoxia
Chelating Agents
inhibitors

Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma

Liu, J., Jiang, W., Zhao, K., Wang, H., Zhou, T., Bai, W., Wang, X., Zhao, T., Huang, C., Gao, S., Qin, T., Yu, W., Yang, B., Li, X., Fu, D., Tan, W., Yang, S., Ren, H. & Hao, J., Mar 1 2019, In : Journal of Experimental Medicine. 216, 3, p. 656-673 18 p.

Research output: Contribution to journalArticle

Open Access
Adenocarcinoma
Neoplasms
Therapeutics
Tumor Microenvironment
Granulocyte-Macrophage Colony-Stimulating Factor